FDA approves highly anticipated weight-loss pill - 13 WTHR Indianapolis

FDA approves highly anticipated weight-loss pill

Posted: Updated:
WASHINGTON -

The Food and Drug Administration is approving a weight loss drug from Vivus Inc. that many doctors consider the most effective among a new generation of anti-obesity pills.

The agency cleared the pill Qsymia for adults who are obese or overweight and have at least one weight-related condition such as high blood pressure, diabetes or high cholesterol.

The FDA says patients taking Qsymia for one year lost and average of 6.7 percent and 8.9 percent of their body weight in two studies. That was more than two other weight loss pills recently reviewed by the agency.

Qsymia is the second weight loss drug approved by the FDA in less than a month. In late June the agency approved Arena Pharmaceutical's pill Belviq.

(Copyright 2012 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.)

Powered by WorldNow
Links to the FCC website to view WTHR and/or WALV’s on-line public inspection files:
WTHR: https://stations.fcc.gov/station-profile/WTHR   ||   WALV: https://stations.fcc.gov/station-profile/WALV
Individuals with disabilities may contact Jill Pursell at publicfile@wthr.com, or 317.655.5602, for assistance with access to the public inspection files.
Powered by WorldNowAll content © Copyright 2000 - 2013 WorldNow and WTHR. For more information on this site, please read our Privacy Policy and Terms of Service.